WEBINAR
Share:

Human-in-the-Loop (HITL) in GMP: Maintaining Human Oversight of AI-Assisted Decisions

Course is now LIVE. Click below to join the session.

This course helps organizations establish clear authority, escalation, and documentation practices for resolving conflicts between AI recommendations and human judgment while maintaining accountability for GMP decisions. 

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
REGISTRATION OPTIONS

Live session Plus
Complimentary 30 Days Streaming access

$290  |  One participant (viewer)

$390  |  Team (2 - 5 participants)

$490 |  Team (6 - 10 participants)

REGISTER FOR THE COURSE

US $290 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $290 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Course ID
    TF1309
  • Live Q&A +
    Post-live Continued Learning
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

 

Why take this course?

Artificial intelligence is increasingly influencing GMP decisions across deviation investigations, batch review, predictive maintenance, quality risk assessment, CAPA effectiveness, and manufacturing support. These systems can identify patterns and process large datasets quickly, but their recommendations may be inaccurate, biased, difficult to explain, or inconsistent with experienced human judgment. At the same time, human decisions can also be affected by cognitive bias, incomplete analysis, and inconsistent reasoning. 


This webinar examines how regulated organizations can manage disagreements between AI recommendations and human judgment without weakening accountability. Participants will consider decision authority, mandatory human review, escalation pathways, documentation practices, and governance controls for AI-assisted decisions. The focus is on determining when recommendations should be accepted, questioned, or overridden, while preserving regulatory responsibility, product quality, patient safety, and inspection readiness within FDA-regulated GMP operations as AI becomes more embedded in routine quality and manufacturing decisions. 

Define Decision Authority When Human and AI Judgments Conflict 

Participants will learn how to distinguish advisory AI output from accountable human decision-making, define when additional review is required, and establish clear authority when recommendations conflict. This supports more consistent decisions while preserving responsibility for product quality, patient safety, regulatory compliance, and the final rationale behind GMP actions. 

Document and Escalate AI-Assisted Decisions Clearly 

Participants will gain practical methods for documenting why an AI recommendation was accepted, challenged, or overridden and for escalating higher-risk disagreements appropriately. Clear records of reasoning, review, evidence, and accountability can reduce ambiguity when inspectors assess how AI-assisted GMP decisions were made and who owned the outcome. 

Key Areas Covered

  • AI as a decision-support tool in GMP operations 
  • Human judgment versus AI-generated recommendations 
  • Human-in-the-Loop decision-making principles 
  • Decision authority, accountability, and mandatory review 
  • Cognitive bias affecting human and AI decisions 
  • Risk-based escalation for conflicting recommendations 
  • Documentation and governance for AI-assisted decisions 
  • FDA oversight expectations and inspection readiness 

Who Must Attend

  • Quality Assurance Departments
  • Quality Control Departments
  • Validation and Computer System Validation personnel
  • Manufacturing Departments
  • Operations Departments
  • Data Integrity professionals
  • Regulatory Affairs Departments
  • IT and Digital Transformation teams
  • AI/ML system owners
  • Compliance and auditing personnel
If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

When a qualified employee overrides an AI recommendation, what evidence makes that decision defensible months later? 

The strongest record explains what the employee knew at the time, why the AI recommendation was considered insufficient, and what evidence supported the alternative decision. A statement such as "SME judgment applied" provides very little protection during a later investigation or inspection. 


This becomes particularly important when the outcome is unfavorable. Reviewers may reconstruct the decision using information that was unavailable when it was originally made. Without a contemporaneous rationale, a reasonable judgment can appear arbitrary after the event. 


Useful documentation identifies the conflicting recommendation, relevant source data, assumptions or limitations identified in the AI output, additional evidence considered, and the reasoning that led to the final disposition. The depth should reflect the potential GMP consequence of the decision. 


A defensible override shows that disagreement with the system resulted from deliberate evaluation rather than preference, intuition, or resistance to an inconvenient recommendation. 

What should happen when employees repeatedly reject recommendations from the same AI system?

Repeated disagreement should trigger evaluation of the system and its intended use rather than being treated indefinitely as a series of unrelated decisions. A pattern of overrides can provide valuable evidence that the system is performing differently from what was expected or is being applied under conditions that were poorly represented during qualification. 


The pattern itself matters. Are overrides concentrated around one product, process condition, decision type, data source, or user group? Do experienced personnel consistently identify the same weakness? Are recommendations technically correct but operationally unusable? 


Inspection friction develops when records show frequent rejection of AI outputs while periodic reviews continue concluding that the system performs acceptably without addressing the discrepancy. 


Override data should therefore become an operational performance signal. Trending the reasons for disagreement can expose inappropriate intended-use boundaries, poor input data, changing process conditions, or weaknesses in the system's decision logic before those weaknesses contribute to a significant quality event.

How should a GMP team handle a situation where the AI recommendation appears better supported by the data than the employee's judgment? 

Seniority or experience alone should not automatically settle the disagreement. If the available evidence supports the AI recommendation more strongly, the employee's alternative conclusion should withstand the same scrutiny that would be applied to any other consequential GMP decision. 


This situation can be uncomfortable because organizations sometimes design escalation processes around the assumption that humans will identify AI errors. The reverse can also occur. An experienced decision-maker may rely on historical practice, incomplete information, or a familiar interpretation that current data no longer supports. 


The appropriate response is structured examination of the disagreement, including the underlying data, assumptions, decision criteria, system limitations, and employee rationale. Higher-risk disagreements may require independent technical or quality review. 


What becomes difficult to defend is a record showing that a well-supported recommendation was rejected simply because an authorized individual preferred another conclusion. Decision authority does not remove the obligation to justify the decision scientifically.

What becomes the biggest inspection vulnerability when AI-assisted decisions produce acceptable outcomes for months without being challenged?

Successful outcomes can create false confidence in the decision process. If recommendations are routinely accepted because previous recommendations appeared reasonable, reviewers may eventually question whether meaningful evaluation is still occurring. 


This weakness can remain hidden because there may be no deviations, rejected batches, complaints, or obvious failures to expose it. Records show approvals, the process continues operating, and the system appears effective. Over time, however, users may stop examining assumptions, source data, unusual outputs, or subtle changes in recommendation patterns. 


Evidence of controlled use should therefore include more than records showing that decisions were approved. Periodic examination of accepted recommendations, unusual cases, near misses, override patterns, and subsequent outcomes can demonstrate that continued reliance remains justified. 


During an inspection, a long history of successful AI-assisted decisions is useful evidence only when the organization can also show that those decisions continued receiving meaningful scrutiny rather than becoming routine acceptance. 

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can join the session, access materials, and manage your learning.

3. Join the Live Training
At the scheduled time, click Join Session and you’ll be connected to the live Webex session with the instructor.

4. Watch Again Anytime
After the session, the playback becomes available on the same course page so you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

Everything related to your webinar: access, materials, playback, and certification — lives in one place.
Simple. Organized. Professional.
Go ahead and reserve your seat with confidence.

Built on 20+ years of global regulatory training experience across FDA, EMA, MHRA, and ICH frameworks.
Trusted by professionals across 80+ countries.

Testimonials

This is an upcoming session. Feedback below reflects experiences from similar programs delivered by our expert faculty.

“Session was easy to follow even for non-core team members. That helped.”
- Production Officer
“Good balance. Not too basic, not too deep. Worked well for mixed team.”
- Manager, Regulatory Affairs
“Team found it useful. Especially for aligning understanding across functions.”
- Director, Operations

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Featured Courses